Elevance Health Revenue 2010-2025 | ELV
Elevance Health annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Elevance Health revenue for the quarter ending March 31, 2025 was $48.891B, a 14.83% increase year-over-year.
- Elevance Health revenue for the twelve months ending March 31, 2025 was $183.325B, a 6.74% increase year-over-year.
- Elevance Health annual revenue for 2024 was $177.011B, a 3.31% increase from 2023.
- Elevance Health annual revenue for 2023 was $171.34B, a 9.42% increase from 2022.
- Elevance Health annual revenue for 2022 was $156.595B, a 12.95% increase from 2021.
| Elevance Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $177,011 |
| 2023 | $171,340 |
| 2022 | $156,595 |
| 2021 | $138,639 |
| 2020 | $121,867 |
| 2019 | $104,213 |
| 2018 | $92,105 |
| 2017 | $90,040 |
| 2016 | $84,863 |
| 2015 | $79,157 |
| 2014 | $73,874 |
| 2013 | $71,024 |
| 2012 | $61,497 |
| 2011 | $60,711 |
| 2010 | $58,699 |
| 2009 | $64,940 |
| Elevance Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $48,891 |
| 2024-12-31 | $45,442 |
| 2024-09-30 | $45,106 |
| 2024-06-30 | $43,886 |
| 2024-03-31 | $42,577 |
| 2023-12-31 | $42,647 |
| 2023-09-30 | $42,849 |
| 2023-06-30 | $43,672 |
| 2023-03-31 | $42,172 |
| 2022-12-31 | $39,929 |
| 2022-09-30 | $39,939 |
| 2022-06-30 | $38,632 |
| 2022-03-31 | $38,095 |
| 2021-12-31 | $36,581 |
| 2021-09-30 | $35,822 |
| 2021-06-30 | $33,851 |
| 2021-03-31 | $32,385 |
| 2020-12-31 | $31,824 |
| 2020-09-30 | $31,158 |
| 2020-06-30 | $29,264 |
| 2020-03-31 | $29,621 |
| 2019-12-31 | $27,407 |
| 2019-09-30 | $26,674 |
| 2019-06-30 | $25,466 |
| 2019-03-31 | $24,666 |
| 2018-12-31 | $23,373 |
| 2018-09-30 | $23,251 |
| 2018-06-30 | $22,944 |
| 2018-03-31 | $22,537 |
| 2017-12-31 | $22,681 |
| 2017-09-30 | $22,426 |
| 2017-06-30 | $22,407 |
| 2017-03-31 | $22,526 |
| 2016-12-31 | $21,714 |
| 2016-09-30 | $21,404 |
| 2016-06-30 | $21,456 |
| 2016-03-31 | $20,289 |
| 2015-12-31 | $20,188 |
| 2015-09-30 | $19,902 |
| 2015-06-30 | $20,016 |
| 2015-03-31 | $19,052 |
| 2014-12-31 | $18,984 |
| 2014-09-30 | $18,557 |
| 2014-06-30 | $18,473 |
| 2014-03-31 | $17,859 |
| 2013-12-31 | $17,902 |
| 2013-09-30 | $17,856 |
| 2013-06-30 | $17,690 |
| 2013-03-31 | $17,576 |
| 2012-12-31 | $15,322 |
| 2012-09-30 | $15,353 |
| 2012-06-30 | $15,407 |
| 2012-03-31 | $15,415 |
| 2011-12-31 | $15,318 |
| 2011-09-30 | $15,398 |
| 2011-06-30 | $15,101 |
| 2011-03-31 | $14,894 |
| 2010-12-31 | $14,622 |
| 2010-09-30 | $14,572 |
| 2010-06-30 | $14,431 |
| 2010-03-31 | $15,073 |
| 2009-12-31 | $18,958 |
| 2009-09-30 | $15,425 |
| 2009-06-30 | $15,413 |
| 2009-03-31 | $15,143 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $78.955B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.621B | 26.94 |
| CVS Health (CVS) | United States | $84.680B | 10.52 |
| Cencora (COR) | United States | $57.765B | 20.10 |
| DiDi Global (DIDIY) | China | $23.297B | 24.75 |
| Natera (NTRA) | United States | $21.640B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.549B | 17.48 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.690B | 0.00 |
| Solventum (SOLV) | United States | $12.990B | 13.75 |
| CochLear (CHEOY) | Australia | $12.847B | 0.00 |
| ICON (ICLR) | Ireland | $12.241B | 11.38 |
| Revvity (RVTY) | United States | $11.865B | 20.42 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.370B | 13.61 |
| Medpace Holdings (MEDP) | United States | $9.269B | 24.62 |
| HealthEquity (HQY) | United States | $8.917B | 39.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.417B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.779B | 15.24 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.688B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.952B | 29.17 |
| BrightSpring Health Services (BTSG) | United States | $3.769B | 34.58 |
| Sotera Health (SHC) | United States | $3.290B | 18.69 |
| Surgery Partners (SGRY) | United States | $2.853B | 37.10 |
| Alignment Healthcare (ALHC) | United States | $2.712B | 0.00 |
| Concentras Parent (CON) | United States | $2.615B | 15.11 |
| Organon (OGN) | United States | $2.587B | 2.75 |
| GeneDx Holdings (WGS) | United States | $2.432B | 93.65 |
| Progyny (PGNY) | United States | $2.080B | 45.79 |
| PACS (PACS) | United States | $1.972B | 0.00 |
| Ardent Health (ARDT) | United States | $1.970B | 8.40 |
| Premier (PINC) | United States | $1.805B | 13.70 |
| GoodRx Holdings (GDRX) | United States | $1.729B | 34.57 |
| Teladoc Health (TDOC) | United States | $1.493B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.271B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.159B | 8.82 |
| CareDx (CDNA) | United States | $1.072B | 16.74 |
| Agilon Health (AGL) | United States | $0.989B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| Nutex Health (NUTX) | United States | $0.766B | 11.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.610B | 4.11 |
| InnovAge Holding (INNV) | United States | $0.574B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| SBC Medicals (SBC) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.465B | 10.47 |
| Omada Health (OMDA) | $0.450B | 0.00 | |
| So-Young (SY) | China | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.370B | 30.42 |
| Performant Healthcare (PHLT) | United States | $0.333B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.324B | 0.00 |
| Beauty Health (SKIN) | United States | $0.265B | 0.00 |
| Oncology Institute (TOI) | United States | $0.223B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 25.83 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| KindlyMD (NAKA) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.067B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.055B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.034B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |